Business

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion.  Shares of ImmunoGen jumped more than 80% Thursday, putting it on track for its highest

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion Read More »

Tata Technologies Makes Dream Stock Market Debut; Shares List With 140% Premium

New Delhi: Tata Technologies made a stellar listing on the Indian stock market on Thursday, in line with expectations from market and experts. Shares of Tata Technologies listed with a bumper premium of 140 per cent, against the issue price of Rs 500. Tata Technologies shares listed at Rs 1,199.95, registering a sharp jump

Tata Technologies Makes Dream Stock Market Debut; Shares List With 140% Premium Read More »

Rs70b money laundering uncovered | The Express Tribune

ISLAMABAD: Pakistan’s tax chief on Wednesday disclosed that two importers of solar panels were involved in a Rs70 billion money laundering scheme after an internal investigation revealed the involvement of five commercial banks in transferring funds to destinations like Switzerland and Singapore. “It is trade-based money laundering,” said Amjad Zubair Tiwana, the Chairman of the

Rs70b money laundering uncovered | The Express Tribune Read More »

Scroll to Top